GlassScriptPhysician profile
Michael W Gromis
NPI 1528068442
$4,404.47
in general payments reported to CMS, 2019-2025
17 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $717 · 2021: $1,272 · 2022: $555 · 2023: $457 · 2024: $372 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $736.81 | 2021-2024 | Arexvy |
| Janssen Pharmaceuticals, INC | $630.27 | 2019-2021 | |
| Abbvie INC. | $576.41 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $475.13 | 2021-2024 | Jardiance |
| Pfizer INC. | $451.72 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $332.70 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $303.22 | 2021 | |
| Intuitive Surgical, INC. | $191.18 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $158.95 | 2022 | |
| Lilly USA, LLC | $150.47 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $116.29 | 2019 | |
| Angiodynamics, INC. | $111.11 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $84.13 | 2019 | |
| Upsher-Smith Laboratories LLC | $33.61 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $19.99 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $17.77 | 2022 | |
| Allergan, INC. | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gromis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.